Latent Healthcare Stigma Profiles and Their Association With Human Immunodeficiency Virus (HIV) Treatment and Care Outcomes Among Women With HIV in the United States: An Intersectional Analysis - Takeaways - MDSpire

Latent Healthcare Stigma Profiles and Their Association With Human Immunodeficiency Virus (HIV) Treatment and Care Outcomes Among Women With HIV in the United States: An Intersectional Analysis

  • By

  • Jennifer P Jain

  • Nadra E Lisha

  • Jae Sevelius

  • Torsten B Neilands

  • Carol Dawson-Rose

  • Mallory O Johnson

  • Ayden Scheim

  • Bulent Turan

  • Adebola Adedimeji

  • Mirjam-Colette Kempf

  • Gypsyamber D’Souza

  • Michelle Floris-Moore

  • Seble Kassaye

  • Anandi Sheth

  • Azure Thompson

  • Deborah Jones Weiss

  • Phyllis C Tien

  • August 6, 2025

  • 0 min

Share

  • 1

    Stigma significantly hinders HIV care among women living with HIV (WWH) in the United States, impacting treatment adherence and health outcomes.

  • 2

    Three stigma profiles were identified: high stigma (3%), low stigma (86%), and anticipated stigma (11%), with high stigma linked to worse health outcomes.

  • 3

    Black WWH who use drugs are disproportionately affected by stigma, leading to lower ART adherence and higher mortality rates compared to other groups.

  • 4

    Intersectional stigma, encompassing racism, sexism, and substance use stigma, exacerbates health inequities and reduces engagement in HIV care.

  • 5

    Reducing stigma and integrating treatment for HIV, substance use, and mental health are essential for improving health outcomes among US WWH.

Original Source(s)

Latent Healthcare Stigma Profiles and Their Association With Human Immunodeficiency Virus (HIV) Treatment and Care Outcomes Among Women With HIV in the United States: An Intersectional Analysis

  • by Jennifer P Jain, Nadra E Lisha, Jae Sevelius, Torsten B Neilands, Carol Dawson-Rose, Mallory O Johnson, Ayden Scheim, Bulent Turan, Adebola Adedimeji, Mirjam-Colette Kempf, Gypsyamber D’Souza, Michelle Floris-Moore, Seble Kassaye, Anandi Sheth, Azure Thompson, Deborah Jones Weiss, Phyllis C Tien

  • August 6, 2025

Related Content

Alcohol Use Disorder Diagnoses and HIV Preexposure Prophylaxis Adherence and Continuation: a Retrospective Cohort Study

Federal Agency Advises Against Allocating Federal Funds for Fentanyl Testing Strips

Hidden Risk: Clinician Substance Use

Longitudinal Swedish study finds physicians and nurses reporting problem drinking or illicit drug use had about twice the risk of rating their care as poor 1 year later